Innovative Blood Test Combining Two Methods Boosts Early Detection of Colorectal Cancer
A new blood test combining immunoprecipitation and multiplex digital PCR offers high accuracy in early colorectal cancer detection with minimal blood volume, promising to improve screening and patient outcomes.
Recent advancements in medical research have introduced a groundbreaking blood test that significantly improves early detection of colorectal cancer (CRC). The number of young individuals under 50 diagnosed with CRC is rising globally, especially in high-income nations, with factors such as Western diets, obesity, limited physical activity, and antibiotic use in early life being potential contributors.
Early diagnosis is crucial because the chances of successful treatment increase dramatically with prompt detection. To address this, researchers from Hahn-Schickard, in collaboration with the University Hospital Schleswig-Holstein and the German Cancer Research Center, have developed a novel blood testing method aimed at identifying cancer markers with higher precision while requiring minimal blood volume.
This new approach, detailed in the journal 31Analytical Chemistry31, involves an innovative combination of immunoprecipitation and multiplex digital PCR—two well-established techniques. The integration allows for high diagnostic accuracy, even with a small blood sample of just 500 microliters, roughly one-fifth of a teaspoon. In a pilot study involving 32 CRC patients and 29 control subjects, the test achieved an impressive sensitivity of 85% and specificity of 90%, outperforming existing methods that require larger blood volumes.
The method holds promise for becoming part of routine screening, especially as it minimizes the practical hurdles associated with traditional tests. Developing the test further, young scientist Judith Sum aims to incorporate additional markers to enhance diagnostic precision. Furthermore, the research team emphasizes raising awareness of the rising CRC risk among younger populations and encourages proactive health monitoring.
While more extensive studies are necessary before clinical implementation, this development marks a significant step forward in non-invasive cancer diagnostics, potentially enabling earlier interventions and better patient outcomes.
Source: https://medicalxpress.com/news/2025-07-coupling-methods-possibilities-early-colorectal.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Genetic Discovery Offers Hope for Chronic Pain Treatment
Researchers have identified a new genetic factor involved in chronic pain, revealing a promising target for innovative pain therapies that could reduce reliance on opioids. The discovery centers around the SLC45A4 gene, which encodes a neuronal polyamine transporter, offering new hope for safe and effective pain management.
US Health Official Robert F. Kennedy Jr. Accuses Medical Journals of Corruption
US Health Secretary Robert F. Kennedy Jr. has accused top medical journals of corruption, citing pharmaceutical industry influence and proposing to create independent publication platforms. Learn more about his controversial claims and their implications for medical research integrity.
Significant Improvements in Long-Term Survival for Patients with Chronic Thromboembolic Pulmonary Hypertension
Recent research highlights significant improvements in long-term survival rates among patients with chronic thromboembolic pulmonary hypertension, driven by advances in surgical and medical treatments over recent decades.
Study Finds Most Epilepsy Patients Wait About a Year for Seizure Control After Treatment Initiation
Most individuals with focal epilepsy experience a year or more of ongoing seizures after starting treatment, highlighting the importance of personalized, persistent medication management for seizure control.